WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.
Michael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, Jack Mottahedeh, Eric R Samuels, Araceli Nunez, Tiffany Phillips, Meeryo Choe, Timothy F Cloughesy, Jorge A Lazareff, Linda M Liau, William H Yong, Thomas G Graeber, Harley I Kornblum, Ming-Fei Lang, Yanzhao Li, Jing Sun
{"title":"WITHDRAWN: Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.","authors":"Michael D Masterman-Smith, Nicholas A Graham, Eduard H Panosyan, Jack Mottahedeh, Eric R Samuels, Araceli Nunez, Tiffany Phillips, Meeryo Choe, Timothy F Cloughesy, Jorge A Lazareff, Linda M Liau, William H Yong, Thomas G Graeber, Harley I Kornblum, Ming-Fei Lang, Yanzhao Li, Jing Sun","doi":"10.4143/crt.2024.859","DOIUrl":null,"url":null,"abstract":"<p><p>Accepted article withdrawn by publisher.</p>","PeriodicalId":49094,"journal":{"name":"Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4143/crt.2024.859","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.